首页|SIB Swiss Institute of Bioinformatics Reports Findings in Machine Learning (Test ing the predictive power of reverse screening to infer drug targets, with the he lp of machine learning)
SIB Swiss Institute of Bioinformatics Reports Findings in Machine Learning (Test ing the predictive power of reverse screening to infer drug targets, with the he lp of machine learning)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Machine Learning is th e subject of a report. According to news reporting out of Lausanne, Switzerland, by NewsRx editors, research stated, “Estimating protein targets of compounds ba sed on the similarity principle-similar molecules are likely to show comparable bioactivity-is a long-standing strategy in drug research. Having previously quan tified this principle, we present here a large-scale evaluation of its predictiv e power for inferring macromolecular targets by reverse screening an unprecedent ed vast external test set of more than 300,000 active small molecules against an other bioactivity set of more than 500,000 compounds.”
LausanneSwitzerlandEuropeCyborgsDrugs and TherapiesEmerging TechnologiesMachine Learning
NETL
NSTL
